Merus (MRUS) Prices 5.5M Common Stock IPO at $10/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St rebounds with broad gains as oil slides sharply
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Merus B.V. (MRUS) IPO Opens Modestly Lower
May 19, 2016 10:28 AM EDTToday's IPO for Merus B.V. (Nasdaq: MRUS) opened for trading at $9.75 after pricing 5,500,000 common shares at an initial public offering price of $10.00 per share, below the expected $14-$16 range. The size of the offering was increased from 4,333,333.
Citigroup Global Markets Inc. and Jefferies LLC are acting as joint book-running managers for the offering, Guggenheim Securities, LLC is acting as lead manager for the offering and Wedbush PacGrow is acting as co-manager for the offering.
Merus B.V. is a clinical-stage immuno-oncology company... More
